Answers are grounded in this paper and cite their sources.
Ziel/Aim: Total-body (TB) PET/CT systems offer increased sensitivity, enabling low-tracer-activity protocols. AI-driven methods can generate CT-like attenuation maps from raw PET data. Combining these approaches may lower subject exposure, making TB-PET/CT suitable for screening healthy individuals to evaluate whole-body metabolism in the absence of disease. Methodik/Methods: 50 healthy controls underwent a test-retest imaging protocol (5-week interval) using a Siemens QUADRA TB-PET system. Subjects fasted for 6 hours before a (113±5) MBq [18F]FDG injection and underwent a 60-min listmode PET scan with a low-dose (1 mSv) CT scan (supine/arms down). Ten controls (6F/4M, BMI 24±4 kg/m²) were included in a first, interim, analysis, focused on the static PET acquired at 55-60 min p.i. Emission counts were removed randomly from PET-listmode files of 55-60 min p.i. to simulate lower tracer activities: 100%, 50%, 25%, 10%, and 5%. Effective doses (ED) were estimated for each activity level. Synthetic CT images (ED=0 mSv) were created with the CTlessPET [ 1 ] software and used for reconstructing attenuation-corrected PET images. The original CTs were segmented in multiple volumes of interest using MOOSE [ 2 ]. Mean standardized uptake-values normalized to body weight (SUVbw) and coefficients of variation (COV) were extracted and compared across the 5 activity levels. Ergebnisse/Results: PET-related ED decreased from (2.9±0.3) mSv at 100% counts to (0.1±0.05) mSv at 5% counts. Mean SUVbw at 100% dose ranged from 0.4±0.1 (lungs) to 3.0±0.3 (kidneys). Minimal SUVbw group variations (%-difference<5%) were noted when reducing the dose to 25% (ED=(0.48±0.02) mSv), except in the lungs (%-diff=7% at 25%), likely due to motion-related PET/CT mismatch. At 10% and 5%, mean%-diff of SUVbw exceeded 10% in most regions, and COV increased, particularly in skeletal muscle and subcutaneous fat segmentations, where it rose from an average of 35% to 55%. Schlussfolgerungen/Conclusions: The effective exposure of healthy controls undergoing TB-FDG-PET/CT for metabolic mapping can be reduced to 0.48 mSv while ensuring robust quantification of organ-based metabolism. Publication History Article published online: 12 March 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
No takes yet. Share an insight, caveat, or question.
Ferrara et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: